The expansion of the market is anticipated to be driven throughout the course of the forecast period by the rising demand for plasmid (pDNA) DNA as well as the rising number of research and development activities carried out by major competitors in the industry. For example, in October 2022, Forge Biologics, a contract development and production firm, declared that their facility in Columbus, Ohio would now be capable of producing plasmid DNA. The services for the synthesis of plasmid DNA include three categories, which include research grade, for discovery, research and development, and other similar applications.
Global Plasmid DNA Manufacturing Market is estimated to be valued at US$ 735.67 million in 2022 and is expected to exhibit a CAGR of 22.5% during the forecast period (2022-2030).
Leading Companies in the Plasmid DNA Manufacturing Industry:
1. Cobra Biologics and Pharmaceutical Services.
Cobra Biologics and Pharmaceutical Services.was founded in 1992 and its headquarter in Keele, Stoke-on-Trent, United Kingdom. The company operates in 35 countries. In2020 Cobra Biologics (Cobra), an international CDMO for biologics and pharmaceuticals, today announced it is working as part of a consortium
